06-07-2022 | JAK inhibitors | Ask the expert | Video
How to talk to patients about JAK inhibitor safety
Speaker: Victoria Ruffing
Following the results of the ORAL Surveillance trial, which demonstrated increased rates of adverse events in people taking JAK inhibitors, Victoria Ruffing provides guidance on how to talk to patients about the risks associated with these medications (6:42).